Andrew Huberman· PhD
And now we're at a point, with FDA approval three years ago of vagus nerve stimulation for the treatment of ischemic stroke, that people can make gains they couldn't have otherwise made.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And now we're at a point, with FDA approval three years ago of vagus nerve stimulation for the treatment of ischemic stroke, that people can make gains they couldn't have otherwise made.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
The gains they made in a double-blind and placebo-controlled trial, published in 'Lancet,' is only in 18 days.